Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment.
Sign Up to like & getrecommendations! Published in 2023 at "Expert review of anticancer therapy"
DOI: 10.1080/14737140.2023.2218090
Abstract: INTRODUCTION The therapeutic armamentarium for the neoadjuvant treatment of triple-negative breast cancer (TNBC) has significantly expanded with the hopes of improving pathological complete response (pCR) rates and the possibility of a cure. However, the data… read more here.
Keywords: neoadjuvant treatment; treatment strategies; patients residual; optimal adjuvant ... See more keywords